Division of General Academic Pediatrics, MassGeneral for Children, 125 Nashua St. Suite 860, Boston, MA 02114, United States of America; Division of Newborn Medicine, MassGeneral for Children, Boston, MA, 02114, United States of America.
Harvard Medical School, Boston, MA, United States of America.
J Subst Use Addict Treat. 2024 Aug;163:209346. doi: 10.1016/j.josat.2024.209346. Epub 2024 May 23.
Racial and ethnic inequities persist in receipt of prenatal care, mental health services, and addiction treatment for pregnant and postpartum individuals with substance use disorder (SUD). Further qualitative work is needed to understand the intersectionality of racial and ethnic discrimination, stigma related to substance use, and gender bias on perinatal SUD care from the perspectives of affected individuals.
Peer interviewers conducted semi-structured qualitative interviews with recently pregnant people of color with SUD in Massachusetts to explore the impact of internalized, interpersonal, and structural racism on prenatal, birthing, and postpartum experiences. The study used a thematic analysis to generate the codebook and double coded transcripts, with an overall kappa coefficient of 0.89. Preliminary themes were triangulated with five participants to inform final theme development.
The study includes 23 participants of diverse racial/ethnic backgrounds: 39% mixed race/ethnicity (including 9% with Native American ancestry), 30% Hispanic or Latinx, 26% Black/African American, 4% Asian. While participants frequently names racial and ethnic discrimination, both interpersonal and structural, as barriers to care, some participants attributed poor experiences to other marginalized identities and experiences, such as having a SUD. Three unique themes emerged from the participants' experiences: 1) Participants of color faced increased scrutiny and mistrust from clinicians and treatment programs; 2) Greater self-advocacy was required from individuals of color to counteract stereotypes and stigma; 3) Experiences related to SUD history and pregnancy status intersected with racism and gender bias to create distinct forms of discrimination.
Pregnant and postpartum people of color affected by perinatal SUD faced pervasive mistrust and unequal standards of care from mostly white healthcare staff and treatment spaces, which negatively impacted their treatment access, addiction medication receipt, postpartum pain management, and ability to retain custody of their children. Key clinical interventions and policy changes identified by participants for antiracist action include personalizing anesthetic plans for adequate peripartum pain control, minimizing reproductive injustices in contraceptive counseling, and addressing misuse of toxicology testing to mitigate inequitable Child Protective Services (CPS) involvement and custody loss.
在接受产前护理、精神健康服务和阿片类物质使用障碍(SUD)孕妇和产后个体的成瘾治疗方面,种族和民族差异仍然存在。需要进一步的定性研究来了解受影响个体的种族和民族歧视、与物质使用相关的耻辱感以及性别偏见在围产期 SUD 护理方面的交叉性。
在马萨诸塞州,同行采访者对患有 SUD 的有色人种最近怀孕的人进行了半结构化定性采访,以探讨内化的、人际的和结构性的种族主义对产前、分娩和产后经历的影响。该研究使用主题分析生成代码本并对转录本进行双重编码,总体kappa 系数为 0.89。初步主题与五名参与者进行了三角剖分,以告知最终主题的发展。
该研究包括 23 名来自不同种族/族裔背景的参与者:39%的混合种族/族裔(包括 9%的美国原住民血统)、30%的西班牙裔或拉丁裔、26%的黑人和/或非裔美国人、4%的亚洲人。虽然参与者经常将种族和族裔歧视,包括人际和结构性歧视,称为护理障碍,但一些参与者将不良经历归因于其他边缘化的身份和经历,例如患有 SUD。参与者的经历中出现了三个独特的主题:1)有色人种参与者面临来自临床医生和治疗计划的更多审查和不信任;2)需要更多的自我倡导来对抗刻板印象和耻辱感;3)与 SUD 史和怀孕状况相关的经历与种族主义和性别偏见相交织,形成了不同形式的歧视。
受围产期 SUD 影响的有色人种孕妇和产后个体面临来自大多数白人医疗保健人员和治疗场所的普遍不信任和不平等的护理标准,这对他们的治疗机会、成瘾药物的获得、产后疼痛管理以及保留孩子抚养权产生了负面影响。参与者为反种族主义行动确定的关键临床干预措施和政策变化包括个性化围产期疼痛控制的麻醉计划、尽量减少避孕咨询中的生殖不公正问题,以及解决毒理学检测的滥用问题,以减轻不平等的儿童保护服务(CPS)参与和监护权丧失。